Follow
Eric Morand
Eric Morand
Verified email at monash.edu
Title
Cited by
Cited by
Year
Trial of anifrolumab in active systemic lupus erythematosus
EF Morand, R Furie, Y Tanaka, IN Bruce, AD Askanase, C Richez, ...
New England Journal of Medicine 382 (3), 211-221, 2020
9762020
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
RF Van Vollenhoven, M Mosca, G Bertsias, D Isenberg, A Kuhn, ...
Annals of the rheumatic diseases 73 (6), 958-967, 2014
8192014
Definition and initial validation of a lupus low disease activity state (LLDAS)
K Franklyn, CS Lau, SV Navarra, W Louthrenoo, A Lateef, L Hamijoyo, ...
Annals of the rheumatic diseases 75 (9), 1615-1621, 2016
6102016
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
J He, X Zhang, Y Wei, X Sun, Y Chen, J Deng, Y Jin, Y Gan, X Hu, R Jia, ...
Nature medicine 22 (9), 991-993, 2016
5252016
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis
EF Morand, M Leech, J Bernhagen
Nature reviews Drug discovery 5 (5), 399-411, 2006
4732006
The BAFF/APRIL system in SLE pathogenesis
FB Vincent, EF Morand, P Schneider, F Mackay
Nature Reviews Rheumatology 10 (6), 365-373, 2014
4492014
Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids
M Leech, C Metz, P Hall, P Hutchinson, K Gianis, M Smith, H Weedon, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1999
4451999
Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective
FB Vincent, EF Morand, K Murphy, F Mackay, X Mariette, C Marcelli
Annals of the rheumatic diseases 72 (2), 165-178, 2013
4412013
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
R Van Vollenhoven, A Voskuyl, G Bertsias, C Aranow, M Aringer, ...
Annals of the rheumatic diseases 76 (3), 554-561, 2017
3792017
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial
RA Furie, EF Morand, IN Bruce, S Manzi, KC Kalunian, EM Vital, TL Ford, ...
The Lancet Rheumatology 1 (4), e208-e219, 2019
3652019
Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2
JL Gregory, EF Morand, SJ McKeown, JA Ralph, P Hall, YH Yang, ...
The Journal of Immunology 177 (11), 8072-8079, 2006
2392006
Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids
L Santos, P Hall, C Metz, R Bucala, EF Morand
Clinical & Experimental Immunology 123 (2), 309-314, 2001
2302001
Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis
M Leech, C Metz, L Santos, T Peng, SR Holdsworth, R Bucala, EF Morand
Arthritis & Rheumatism: Official Journal of the American College of …, 1998
2251998
Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity
H Yang, L Xia, J Chen, S Zhang, V Martin, Q Li, S Lin, J Chen, J Calmette, ...
Nature medicine 25 (9), 1428-1441, 2019
2242019
A miR-19 regulon that controls NF-κB signaling
MP Gantier, HJ Stunden, CE McCoy, MA Behlke, D Wang, ...
Nucleic acids research 40 (16), 8048-8058, 2012
2102012
Macrophage migration inhibitory factor in systemic lupus erythematosus.
A Foote, EM Briganti, Y Kipen, L Santos, M Leech, EF Morand
The Journal of rheumatology 31 (2), 268-273, 2004
2022004
Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen‐induced arthritis
YH Yang, EF Morand, SJ Getting, M Paul‐Clark, DL Liu, S Yona, ...
Arthritis & Rheumatism 50 (3), 976-984, 2004
2012004
Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor
AV Sampey, PH Hall, RA Mitchell, CN Metz, EF Morand
Arthritis & Rheumatism: Official Journal of the American College of …, 2001
1822001
2021 DORIS definition of remission in SLE: final recommendations from an international task force
RF van Vollenhoven, G Bertsias, A Doria, D Isenberg, E Morand, MA Petri, ...
Lupus Science & Medicine 8 (1), e000538, 2021
1732021
Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations
EF Morand, M Leech, H Weedon, C Metz, R Bucala, MD Smith
Rheumatology 41 (5), 558-562, 2002
1682002
The system can't perform the operation now. Try again later.
Articles 1–20